RxDoctor Payments Data

Randy Heisser, MD

Family Medicine · East Ridge, TNNPI 1689620999

Payments from drug & device makers

$6,834in general payments, 2019–2025

Across 147 payments — averaging $46.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • AstraZeneca$1K
  • AbbVie$445
  • Otsuka America Pharmaceutical, Inc.$416
  • Teva Pharmaceuticals USA, Inc.$326
  • Amgen$287
  • plus $3K from 35 others

What the payments were for

  • Food & beverage$6,828100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,834 in reported general payments places this provider in the 85th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$101,214
Medicare patients
354
Services billed
1,206

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban913$230,557
XifaxanRifaximin50$58,652
XareltoRivaroxaban171$47,649
FarxigaDapagliflozin Propanediol64$20,713
JanuviaSitagliptin Phosphate27$16,477
MyrbetriqMirabegron60$15,407
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog72$11,802
EntrestoSacubitril/Valsartan34$10,737
Levetiracetam154$9,314
Fluticasone-SalmeterolFluticasone Propion/Salmeterol53$8,822
Quetiapine Fumarate274$6,628
Lantus SolostarInsulin Glargine,hum.Rec.Anlog124$6,540
Divalproex Sodium113$6,341
Levothyroxine Sodium674$6,304
Pantoprazole Sodium278$6,093

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$24$58,65250 claims
Johnson & JohnsonXarelto$1,323$47,649171 claims
AstraZenecaFarxiga$1,217$20,71364 claims
MerckJanuvia$13$16,47727 claims
Astellas Pharma US IncMyrbetriq$131$15,40760 claims
GSKIncruse Ellipta, Arexvy, Shingrix$98$14,27355 claims
NovartisEntresto$164$10,73734 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in East Ridge

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →